Status:
COMPLETED
Observational Study of Synovian® Inj. in Patients With Osteoarthritis in the Knee
Lead Sponsor:
LG Chem
Conditions:
Osteoarthritis in the Knee
Eligibility:
All Genders
19+ years
Brief Summary
This is an observational study to evaluate the injection site reactions of Synovian® Inj. in patients with osteoarthritis in the knee
Eligibility Criteria
Inclusion
- Adult male or female patient of over 19 years of age
- A patient diagnosed with knee osteoarthritis
- A patient who has been informed of the purpose, method of the study and signed the written informed consent form.
Exclusion
- A patient who shows hypersensitive reaction to the Synovian® Inj. or to the ingredients of Synovian® Inj.
- A patient with infection at the joint
- A patient with skin infection or skin disease at the injection area
- A patient diagnosed with osteoarthritis with the Kellgren \& Lawrence Grade IV in X-ray within 12 months before enrollment of this study.
Key Trial Info
Start Date :
March 9 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 8 2019
Estimated Enrollment :
1949 Patients enrolled
Trial Details
Trial ID
NCT04369261
Start Date
March 9 2018
End Date
August 8 2019
Last Update
April 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hanyang University GURI Hospital
Guri-si, Gyeonggi-do, South Korea, 11923